App-Quantinova.ai

CTC Clusters, Cancer Stemness, and New Treatment Strategies

Liu, H - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Biology, Vulnerabilities and Clinical Implications of CTC Clusters

Aceto, N - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Detect III/IV study trial - The multicenter study program in patients with HER2-negative MBC and circulating tumor cells

Sabrina Krause - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Ribociclib

A comparative study of two detection platforms of circulating tumour cells in patients with metastatic breast cancer

Dieter Peeters - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Prospective genomic and PD-L1 profiling of patients with residual triple negative breast cancer after neoadjuvant chemotherapy

Hanna Yoko Irie - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Triple-negative breast cancer

Atezolizumab

Next generation sequencing-based gene variant-oriented characterization in metastatic breast cancer: An innovative analysis using ctDNA

Lorenzo Gerratana - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patients

Corinna Keup - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

The clinical utility of mutations detected on circulating tumor cells: A proof of concept study based on a metastasized breast cancer index patient

Andr Franken - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Presence of circulating tumor cell clusters and elevated platelet counts interactively predict disease progression in advanced-stage breast cancer patients

Chun Wang - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Pancreatic Adenocarcinoma Surgery: No Difference In Circulating Tumor Cells And Recurrence Between Desflurane And Propofol Anesthesia. A Randomized Controlled Trial.

Martin Schlapfer - American Society of Anesthesiologists (ASA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

Desflurane

Localization and differential expression of HLA-G in term human fetal membranes.

Alan J. Lee - Society for Maternal-Fetal Medicine (SMFM) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Choriocarcinoma

N/A

Expression of pd-l1 on circulating stromal cells predicts immunotherapy response in unresectable non-small cell lung carcinoma after definitive chemoradiotherapy

Daniel L. Adams - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

Atezolizumab

Vessel normalization following LDH-A knockdown in murine breast tumors

Inna Serganova - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Pimonidazole

In situ detection of CLDN18.2 RNA in circulating tumor cells in gastrointestinal cancer

Xiaoyi Chong - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gastric Cancer

N/A

Circulating tumor cells, tumor- and endothelium- derived extracellular vesicles, but not circulating endothelial cells associate with poor prognosis in colorectal cancer

Afroditi Nanou - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Detection of cell-free DNA alterations in AR and its enhancer significantly outperformed CTC AR-V7 detection for identifying treatment resistance in patients with metastatic prostate cancer

Pradeep S. Chauhan - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Androgen Tear

Monocyte-derived macrophages contribute to the inflammation-induced survival of experimental micrometastases in the lung

Arif A. Arif - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Extrinsic allergic alveolitis

Bleomycin

Isolation and genetic characterization of circulating tumor cells from cancer of unknown primary

Elisa Porcellini - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Metabolic switch from glycolysis to oxidative phosphorylation (ox-phos) provides survival advantage to anti-androgen-treated prostate cancer cells and make them vulnerable to mitochondrial metabolism inhibitors IACS-010759 and CB-839

Hirak S. Basu - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

IACS-010759

Large, polymorphonuclear circulating cancer-associated cell with dual epithelial and macrophage/myeloid phenotype is prognostic in non-small cell lung cancer and has an impact on anti-tumor immune responses

Yariswamy Manjunath - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Filters

1671 Abstracts